Furosemide Tablets recall: CGMP Deviations
Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01
Why was Furosemide Tablets recalled?
CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lots# H03125, H03225, H03325, Exp Date: 2027/08
- Product
- Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01
- Recalling firm
- Leading Pharma, LLC
- Quantity
- 9384 bottles
- Distribution
- US Nationwide.
- Recall date
- April 29, 2026
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)